Published in J Exp Med on August 01, 1972
Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes. J Clin Invest (1973) 5.31
Isolation and functional characterization of human intestinal mucosal lymphoid cells. J Clin Invest (1977) 5.09
Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. J Exp Med (1973) 5.03
The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest (1974) 4.90
Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases. J Clin Invest (1973) 4.69
Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy. Clin Exp Immunol (1973) 4.12
Separation of human breast cancer cells from blood by differential dielectric affinity. Proc Natl Acad Sci U S A (1995) 4.00
Suppressor thymus-derived lymphocytes in fungal infection. J Clin Invest (1976) 3.65
Synthesis of the second component of complement by long-term primary cultures of human monocytes. J Exp Med (1976) 3.64
Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes. J Exp Med (1980) 3.50
Selective triggering of human T and B lymphocytes in vitro by polyclonal mitogens. J Exp Med (1974) 3.39
Inhibition of multiplication of Toxoplasma gondii by human monocytes exposed to T-lymphocyte products. J Exp Med (1975) 3.17
Identification of a human T lymphocyte surface protein associated with the E-rosette receptor. J Exp Med (1981) 3.06
The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor. J Exp Med (1976) 3.04
Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma. Ann Surg (1977) 3.02
Clonal proliferation of PHA-stimulated human lymphocytes in soft agar culture. Immunology (1975) 2.98
Studies of T- and B-lymphocytes in patients with connective tissue diseases. J Clin Invest (1973) 2.84
Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J Exp Med (1979) 2.80
Rosetting of human red blood cells to thymocytes and thymus-derived cells. Clin Exp Immunol (1973) 2.39
Sheep red cell binding to human lymphocytes treated with neuraminidase; enhancement of T cell binding and identification of a subpopulation of B cells. J Exp Med (1973) 2.37
Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet (1995) 2.35
Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet (1988) 2.35
Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins. Infect Immun (1978) 2.35
Impaired lymphocyte function in aged humans. J Clin Invest (1974) 2.32
The Sézary syndrome: a malignant proliferation of helper T cells. J Clin Invest (1976) 2.32
Replication and persistence of measles virus in defined subpopulations of human leukocytes. J Virol (1975) 2.30
Epstein-barr virus-negative human malignant T-cell lines. J Exp Med (1974) 2.28
Cellular interactions in the proliferative response of human T and B lymphocytes to phytomitogens and allogeneic lymphocytes. J Exp Med (1974) 2.27
Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism. J Exp Med (1974) 2.22
Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet (1991) 2.22
Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus. J Clin Invest (1973) 2.19
Effects on C-reactive protein on the lymphoid system. I. Binding to thymus-dependent lymphocytes and alteration of their functions. J Exp Med (1975) 2.17
Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans. Infect Immun (1976) 2.16
Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker. J Exp Med (1974) 2.13
Lymphocyte binding of aggregated IgG and surface Ig staining in chronic lymphocytic leukaemia. Clin Exp Immunol (1973) 2.11
Alternate-day prednisone therapy and human lymphocyte subpopulations. J Clin Invest (1975) 2.10
Human lymphocyte antigens: production of a monoclonal antibody that defines functional thymus-derived lymphocyte subsets. Proc Natl Acad Sci U S A (1979) 2.07
Peripheral lymphocyte subpopulations in human falciparum malaria. Clin Exp Immunol (1976) 2.03
Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A (1982) 1.99
Properties and distribution of a lectin-like hemagglutinin differentially expressed by murine stromal tissue macrophages. J Exp Med (1986) 1.96
Characterization of mononuclear effector cells in human blood. Clin Exp Immunol (1976) 1.96
Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody. Infect Immun (1979) 1.94
Epstein-Barr virus susceptibility of normal human B lymphocyte populations. J Exp Med (1984) 1.94
T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens. Clin Exp Immunol (1976) 1.91
Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds. J Clin Invest (1977) 1.89
Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes. Clin Exp Immunol (1976) 1.87
Dielectric properties of human leukocyte subpopulations determined by electrorotation as a cell separation criterion. Biophys J (1999) 1.82
Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humans. Proc Natl Acad Sci U S A (1980) 1.81
A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia. Proc Natl Acad Sci U S A (1984) 1.79
Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies. J Exp Med (1982) 1.74
Subpopulations of human T lymphocytes. I. Studies in immunodeficient patients. Clin Exp Immunol (1977) 1.69
In vitro lymphocyte responses of coccidioidin skin test-positive and -negative persons to coccidioidin, spherulin, and a coccidioides cell wall antigen. Infect Immun (1977) 1.69
Rosette-forming T lymphocytes and cell-mediated immunity in malnutrition. Br Med J (1974) 1.66
Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein. J Exp Med (1975) 1.66
T and B lymphocytes in peripheral blood and tissue lesions in Sjögren's syndrome. J Clin Invest (1974) 1.63
Blocking and redistribution ("capping") of antigen receptors on T and B lymphocytes by anti-immunoglobulin antibody. J Exp Med (1973) 1.63
Mycobacterial isolations in young adults with cystic fibrosis. Thorax (1984) 1.60
Formation of multinucleated giant cells from human monocyte precursors. Mediation by a soluble protein from antigen-and mitogen-stimulated lymphocytes. J Exp Med (1982) 1.59
Severe acquired immunodeficiency in European homosexual men. Br Med J (Clin Res Ed) (1982) 1.59
Studies of peripheral blood T-and B-lymphocytes in acute infections. Infect Immun (1974) 1.58
Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1978) 1.54
Identification and function of T cells in the peripheral blood of patients with hypogammaglobulinaemia. Clin Exp Immunol (1974) 1.53
Localization of T and B cells and alpha fetoprotein in hepatic biopsies from patients with liver disease. J Clin Invest (1975) 1.52
Lymphocyte activation. V. Quantitation of the proliferative responses to mitogens using defined T and B cell populations. Clin Exp Immunol (1973) 1.52
Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen). J Exp Med (1985) 1.51
Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers. Infect Immun (1974) 1.50
Characterization of human lymphoid cell-mediated antibody-dependent cytotoxicity (LDAC). Clin Exp Immunol (1974) 1.50
Malaria antigen-specific T-cell responsiveness during infection with Plasmodium falciparum. Clin Exp Immunol (1977) 1.50
Monoclonal lymphocyte population in human plasma cell myeloma. Clin Exp Immunol (1974) 1.49
Lymphocyte subpopulations in the blood of newborn infants. Clin Exp Immunol (1974) 1.48
Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma. J Clin Invest (1980) 1.48
Function and distribution pattern of human T lymphocytes. I. Production of anti-T lymphocyte specific sera as estimated by cytotoxicity and elimination of function of lymphocytes. Clin Exp Immunol (1973) 1.46
Loss of circulating T lymphocytes with normal levels of B and 'null' lymphocytes in Thai adults with malaria. Clin Exp Immunol (1979) 1.45
Suppression of human T-cell mitogenesis and E-rosette formation by the monoclonal antibody OKT11A. Immunology (1981) 1.44
Fractionated total lymphoid irradiation as preparative immunosuppression in high risk renal transplantation: clinical and immunological studies. Ann Surg (1982) 1.44
Lymphocyte subpopulations in sarcoidosis. Clin Exp Immunol (1974) 1.43
Immunological studies of patients with asbestosis. II, Studies of circulating lymphoid cell numbers and humoral immunity. Clin Exp Immunol (1977) 1.40
Human peripheral lymphocytes bearing both B-cell complement receptors and T-cell characteristics for sheep erythrocytes detected by a mixed rosette method. Clin Exp Immunol (1974) 1.40
Heterologous specific antiserum for identification of human T lymphocytes. Clin Exp Immunol (1974) 1.40
Studies on synovial fluid lymphocytes in rheumatoid arthritis. Ann Rheum Dis (1974) 1.39
Rosette formation by mouse lymphocytes. II. T-cell specificities in a CRL subpopulation. Clin Exp Immunol (1974) 1.39
Formation of auto-rosettes by peripheral blood lymphocytes. Clin Exp Immunol (1975) 1.37
The effect of anaesthesia on the lymphocyte response to phytohaemagglutinin. Clin Exp Immunol (1974) 1.37
Circulating lymphocyte subpopulations in Hashimoto thyroiditis. Clin Exp Immunol (1973) 1.36
Histamine regulates lymphocyte mitogenic responses through activation of specific H1 and H2 histamine receptors. Immunology (1980) 1.35
Immunoreactivity by intrinsic lymphoid cells in colorectal carcinoma. Br J Cancer (1979) 1.35
Antibody-associated lymphotoxin in acute infection. J Clin Invest (1973) 1.34
A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias. Am J Pathol (1978) 1.33
Enumeration and isolation of human T and B lymphocytes by rosette formation with antibody-coated erythrocytes. Clin Exp Immunol (1975) 1.32
Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases. Am J Pathol (1979) 1.32
Human T lymphocyte "E" rosette function. I. A process modulated by intracellular cyclic AMP. J Exp Med (1974) 1.31
Specific and non-specific lymphocyte cytotoxicity in colon carcinoma. Br J Cancer (1981) 1.31
In vitro activation of human T and B lymphocytes by pokeweed mitogen. Clin Exp Immunol (1975) 1.31
Cytotoxic lymphocytes from normal donors. A functional marker of human non-T lymphocytes. Clin Exp Immunol (1975) 1.31
Malignant lymphomas--a conceptual understanding of morphologic diversity. A review. Am J Pathol (1979) 1.30
Immunobiology of primary intracranial tumours. II. Analysis of lymphocyte subpopulations in patients with primary brain tumours. Clin Exp Immunol (1977) 1.29
Study of human T and B lymphocytes with heterologous antisera. I Preparation, specificity and properties of antisera. Immunology (1976) 1.29
Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29
Differentiation of human bone marrow cells into T lymphocytes by in vitro incubation with thymic extracts. Clin Exp Immunol (1974) 1.29
Binding of sheep red blood cells to a large population of human lymphocytes. Nature (1971) 7.67
Identification of human T and B lymphocytes in normal peripheral blood and in chronic lymphocytic leukaemia. Lancet (1971) 7.25
Rosette formation by peripheral lymphocytes. Clin Exp Immunol (1970) 6.34
Rosette-formation between human lymphocytes and sheep red cells not involving immunoglobulin receptors. Int Arch Allergy Appl Immunol (1970) 5.92
In vivo specific antigen recognition by rosette forming cells. Nature (1970) 4.78
In vitro evaluation of immunosuppressive drugs. Nature (1969) 4.70
Receptor sites for complement on certain human peripheral blood lymphocytes. J Immunol (1970) 4.09
Is azathioprine a better immunosuppressive than 6-mercaptopurine? Clin Exp Immunol (1971) 3.47
Cytotoxic effects of lymphoid cells in vitro. Adv Immunol (1969) 8.18
"Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol (1975) 7.61
Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res (1968) 7.53
Rosette-formation between human lymphocytes and sheep red cells not involving immunoglobulin receptors. Int Arch Allergy Appl Immunol (1970) 5.92
Cell separation on antigen-coated columns. Elimination of high rate antibody-forming cells and immunological memory cells. J Exp Med (1969) 5.38
Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A (1974) 5.13
Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. J Exp Med (1973) 5.03
"Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol (1975) 4.86
Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells. Transplant Rev (1972) 4.71
Antibody synthesis at the cellular level. Antibody-induced suppression of 7S antibody synthesis. J Exp Med (1966) 4.49
Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma. Lancet (1972) 4.36
Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci U S A (1975) 4.21
Cytotoxic potential of stimulated human lymphocytes. J Exp Med (1967) 3.89
Quantitative studies on phytohaemagglutinin-induced cytotoxicity by human lymphocytes against homologous cells in tissue culture. Immunology (1967) 3.87
The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem (1997) 3.82
Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature (1978) 3.72
Separation of cells according to surface antigens by the use of antibody-coated columns. Fractionation of cells carrying immunoglobulins and blood group antigen. Scand J Immunol (1972) 3.52
Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proc Natl Acad Sci U S A (1987) 3.47
Two different VH gene products make up the T-cell receptors. Scand J Immunol (1976) 3.32
An analysis of the murine NK cell as to structure, function and biological relevance. Immunol Rev (1979) 3.15
Lymphocyte stimulation by protein A of Staphylococcus aureus. Eur J Immunol (1976) 3.13
Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med (2001) 3.11
The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood (2000) 3.09
Separation of normal and immune lymphoid cells by antigen-coated coated columns. Antigen-binding characteristics of membrane antibodies as analyzed by hapten-protein antigens. J Exp Med (1970) 3.08
Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol (1977) 3.05
Antigen-binding, idiotypic T-lymphocyte receptors. Contemp Top Immunobiol (1977) 3.00
Cells mediating specific in vitro cytotoxicity. II. Probable autonomy of thymus-processed lymphocytes (T cells) for the killing of allogeneic target cells. J Exp Med (1972) 3.00
Surface markers on human b and t lymphocytes. VI. Cytotoxicity against cell lines as a functional marker for lymphocyte subpopulations. Int J Cancer (1975) 2.81
Evidence for an immunoglobulin-dependent antigen-specific helper T cell. Proc Natl Acad Sci U S A (1977) 2.72
Phytohaemagglutinin-induced cytotoxic action of unsensitized immunologically competent cells on allogeneic and xenogeneic tissue culture cells. Nature (1965) 2.69
Cellular signalling in programmed cell death (apoptosis). Immunol Today (1990) 2.64
Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature (1977) 2.58
Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum (1986) 2.56
Human lymphocyte subpopulations: classification according to surface markers and-or functional characteristics. Transplant Rev (1973) 2.53
Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers. Proc Natl Acad Sci U S A (1993) 2.49
Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus. Diabet Med (1999) 2.48
Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo. Nature (1977) 2.39
Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet (1986) 2.38
Biological significance of carbohydrate chains on monoclonal antibodies. Proc Natl Acad Sci U S A (1983) 2.33
Specific transplantation tolerance induced by autoimmunization against the individual's own, naturally occurring idiotypic, antigen-binding receptors. J Exp Med (1976) 2.29
Long term growth in vitro of human T cell blasts with maintenance of specificity and function. J Immunol (1979) 2.25
Haemolytic activity of human blood monocytes. Lysis of human erythrocytes treated with anti-A serum. Clin Exp Immunol (1973) 2.21
Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells. Scand J Immunol (1976) 2.18
Cytotoxic action of stimulated lymphocytes on allogenic and autologous erythrocytes. Science (1968) 2.17
Surface markers on human B and T lymphocytes. IV. Distribution of surface markers on resting and blast-transformed lymphocytes. Scand J Immunol (1974) 2.16
In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen. J Exp Med (1972) 2.13
Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems. J Exp Med (1976) 2.11
Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parental monocytoid cell line and its subclones. Virology (1987) 2.11
Cells mediating specific in vitro cytotoxicity. I. Detection of receptor-bearing lymphocytes. J Exp Med (1971) 2.09
Specific fractionation of immunocompetent cells. Transplant Rev (1970) 2.04
The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect. J Immunol (1979) 2.02
Demonstration of heavy and light chain antigenic determinants on the cell-bound receptor for antigen. Similarities between membrane-attached and humoral antibodies produced by the same cell. J Exp Med (1970) 2.01
Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A (1982) 1.99
Androgen treatment of abdominally obese men. Obes Res (1993) 1.99
Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. J Immunol (1989) 1.98
T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand J Immunol (1985) 1.96
Studies at the cellular level of the 19S immune response. Acta Pathol Microbiol Scand (1966) 1.93
Analysis of clinical specimens by hybridisation with probe containing repetitive DNA from Plasmodium falciparum. A novel approach to malaria diagnosis. Lancet (1984) 1.92
EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients. Int J Cancer (1976) 1.81
Lysis of antibody-treated human erythrocytes by human leukocytes and macrophages in tissue culture. Int Arch Allergy Appl Immunol (1972) 1.77
Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies. J Exp Med (1982) 1.74
The in vitro cytotoxicity of human lymphocytes: the effect of metabolic inhibitors. Exp Cell Res (1967) 1.72
Recycling and target binding capacity of human natural killer cells. J Exp Med (1981) 1.71
Do we need a gender-specific total knee replacement? A randomised controlled trial comparing a high-flex and a gender-specific posterior design. J Bone Joint Surg Br (2012) 1.71
Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV. J Immunol (1990) 1.69
T cell receptor V-segment frequencies in peripheral blood T cells correlate with human leukocyte antigen type. J Exp Med (1991) 1.69
Coexpression of human immunodeficiency virus envelope proteins and tat from a single simian virus 40 late replacement vector. Proc Natl Acad Sci U S A (1988) 1.66
Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. Br J Haematol (2000) 1.66
A simple rosette assay for demonstration of complement receptor sites using complement-coated zymosan beads. Eur J Immunol (1976) 1.66
Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation (2001) 1.63
Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. V. Biochemical and serological characteristics of naturally occurring, soluble antigen-binding T-lymphocyte-derived molecules. Scand J Immunol (1976) 1.63
Immune deficiency in family members of patients with Hodgkin's disease. Cancer (1990) 1.61
Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. J Immunol (1987) 1.61
The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord (1992) 1.61
Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation. Infect Immun (1976) 1.61
Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect Immun (1993) 1.59
Natural killer cells may be the only cells in normal mouse lymphoid cell populations endowed with cytolytic ability for antibody-coated tumour target cells. Scand J Immunol (1978) 1.58
Surface markers on human B and T-lymphocytes. IX. Two-color immunofluorescence studies on the association between ebv receptors and complement receptors on the surface of lymphoid cell lines. Int J Cancer (1976) 1.58
Role of T lymphocytes in collagen II induced arthritis in rats. Clin Exp Immunol (1983) 1.58
Impaired phytohaemagglutinin-induced cytotoxicity in vitro of lymphocytes from patients with Hodgkin's disease or chronic lymphatic leukaemia. Clin Exp Immunol (1967) 1.57
The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism (1992) 1.56
T-cell idiotypes are linked to immunoglobulin heavy chain genes. Nature (1976) 1.55
Lung and blood T-cell receptor repertoire in extrinsic allergic alveolitis. Eur Respir J (1997) 1.54
Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers. J Infect Dis (1990) 1.54
Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates. Proc Natl Acad Sci U S A (1996) 1.54
Labeled staphylococcal protein A as an immunological probe in the analysis of cell surface markers. Scand J Immunol (1974) 1.52
A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res (2000) 1.52
Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease. J Intern Med (1995) 1.51
A radioimmunoassay of cellular surface antigens on living cells using iodinated soluble protein A from Staphylococcus aureus. J Immunol Methods (1975) 1.50
Variation of flavonoid patterns in Hordeum spontaneum and H. agriocrithon. Hereditas (1975) 1.49
Monoclonal lymphocyte population in human plasma cell myeloma. Clin Exp Immunol (1974) 1.49
Relationship between HLA-DR-expressing cells and T lymphocytes of different subsets in rheumatoid synovial tissue. Scand J Immunol (1981) 1.48
Clonal cell surface structures related to differentiation, activation and homing in B-cell chronic lymphocytic leukemia and monoclonal lymphocytosis of undetermined significance. Eur J Haematol (1989) 1.48